moxifloxacin has been researched along with Pregnancy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkerman, OW; Alffenaar, JC; Bolhuis, MS; de Lange, WC; Kerstjens, HA; Oswald, LM; van der Werf, TS; Van Kampenhout, E | 1 |
| Huang, X; Wang, Y | 1 |
| Brandt, CT; Figueiredo Filho, CA; Maior, GIS; Marquis, VWPB; Mascena, GV; Moura, LCRV; Paz, ARD | 1 |
| Chilet-Rosell, E; Pardo, MA; Ruiz-Cantero, MT | 1 |
| Meister, R; Oppermann, M; Padberg, S; Panse, M; Schaefer, C; Wacker, E; Weber-Schoendorfer, C | 1 |
| Brown-Elliott, BA; Chao, AS; Chiu, CH; Griffith, DE; Leu, HS; Lin, CS; Wu, TL; Wu, TS; Yang, CH | 1 |
| Beksac, MS; Katlan, D; Kir, S; Nemutlu, E; Ozyuncu, O | 2 |
| Beksaç, MS; Eroglu, H; Katlan, D; Kir, S; Nemutlu, E; Oyüncü, O; Ozek, A; Özyüncü, Ö | 1 |
| Benjamin, DK; Cohen-Wolkowiez, M; Laughon, MM; Massaro, MM; Smith, B; Watt, KM | 1 |
| Broad, JM; Golden, MR; Manhart, LE | 1 |
1 review(s) available for moxifloxacin and Pregnancy
| Article | Year |
|---|---|
Gender analysis of moxifloxacin clinical trials.
Topics: Anti-Bacterial Agents; Aza Compounds; Clinical Trials as Topic; Female; Fluoroquinolones; Guideline Adherence; Humans; Male; Moxifloxacin; Pregnancy; Quinolines; Sex Factors; United States; United States Food and Drug Administration | 2014 |
11 other study(ies) available for moxifloxacin and Pregnancy
| Article | Year |
|---|---|
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Female; Fluoroquinolones; Humans; Linezolid; Moxifloxacin; Mycobacterium tuberculosis; Pregnancy; Tuberculosis, Multidrug-Resistant | 2017 |
Sepsis after uterine artery embolization-assisted termination of pregnancy with complete placenta previa: A case report.
Topics: Abortion, Therapeutic; Adult; Anti-Bacterial Agents; Cesarean Section; Female; Fluoroquinolones; Humans; Moxifloxacin; Placenta Previa; Pregnancy; Sepsis; Serratia Infections; Serratia marcescens; Uterine Artery Embolization; Uterine Hemorrhage | 2018 |
Role of moxifloxacin-dexamethasone in cardiac histomorphometric findings among Wistar rats from infected mothers.
Topics: Animals; Animals, Newborn; Dexamethasone; Disease Models, Animal; Female; Fluoroquinolones; Heart; Moxifloxacin; Myocardium; Organogenesis; Peritonitis; Pregnancy; Pregnancy Complications; Prospective Studies; Rats; Rats, Wistar | 2018 |
Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.
Topics: Abnormalities, Drug-Induced; Abortion, Legal; Abortion, Spontaneous; Adult; Anti-Bacterial Agents; Birth Weight; Case-Control Studies; Female; Fluoroquinolones; Gestational Age; Humans; Moxifloxacin; Odds Ratio; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies | 2014 |
Postcesarean section wound infection caused by Mycobacterium massiliense.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cesarean Section; Chaperonin 60; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Electrophoresis, Gel, Pulsed-Field; Female; Fluoroquinolones; Humans; Imipenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Mycobacterium Infections; Nontuberculous Mycobacteria; Pregnancy; Surgical Wound Infection; Teicoplanin | 2016 |
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cefepime; Cefoperazone; Cephalosporins; Female; Fetal Blood; Fluoroquinolones; Humans; Infant, Newborn; Injections, Intravenous; Levofloxacin; Maternal-Fetal Exchange; Moxifloxacin; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Quinolines | 2010 |
Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection.
Topics: Aza Compounds; Cesarean Section; Chromatography, High Pressure Liquid; Drug Stability; Female; Fluoroquinolones; Humans; Moxifloxacin; Pregnancy; Quinolines; Spectrometry, Fluorescence | 2010 |
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.
Topics: Adult; Amniocentesis; Amniotic Fluid; Anti-Bacterial Agents; Aza Compounds; Cefixime; Female; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Pregnancy; Quinolines; Statistics, Nonparametric | 2010 |
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Doxycycline; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Pregnancy; Quinolines; Treatment Outcome | 2012 |
Mycoplasma genitalium: should we treat and how?
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Infertility, Female; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Quinolines; Treatment Outcome; Urethritis; Uterine Cervicitis | 2011 |
Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar).
Topics: Adult; Aza Compounds; Child; Conjunctivitis, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ophthalmic Solutions; Pregnancy; Quinolines | 2004 |